Business Context and Reporting Period
Company: Redhill Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 2, 2021
Reporting Period: The filing serves as a cover document for the month of September 2021, incorporating by reference financial and operational highlights for the second quarter ended June 30, 2021.
Key Financial Metrics
This Form 6-K is a cover document and does not contain specific numerical data within its text. It incorporates by reference Exhibits 99.1 and 99.2, which contain the Condensed Consolidated Interim Statements of Comprehensive Loss, Financial Position, and Cash Flows for the quarter ended June 30, 2021.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide clear values for these metrics. Specific figures are located in the incorporated exhibits (Exhibit 99.1) referenced in the document.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It references "Commercial Highlights" and "R&D Highlights" in the incorporated exhibits, but the specific nature of these changes is not described in the provided text.
Guidance, Outlook, and Management Commentary
Management Commentary: The filing incorporates a press release (Exhibit 1) announcing that Redhill Biopharma will present at the H.C. Wainwright Annual Global Investment Conference and the Cantor Global Healthcare Conference.
Guidance and Risks: The filing text does not provide specific forward-looking guidance, risk factors, or contingencies. These details are presumed to be in the incorporated exhibits or the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual financial statements (Loss, Position, Cash Flows) for the quarter ended June 30, 2021, as they are not included in the cover text.
- Verify the specific details of the "Commercial Highlights" and "R&D Highlights" referenced in the filing.
- Confirm the dates and outcomes of the presentations at the H.C. Wainwright and Cantor Global Healthcare conferences mentioned in Exhibit 1.
- Check the referenced Registration Statements (Forms S-8 and F-3) for details on outstanding securities and capital structure.